AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-52 Cr | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr |
What is the latest Total Non-Current Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹1,462 Cr |
| Mar2023 | ₹1,246 Cr |
| Mar2022 | ₹1,153 Cr |
| Mar2021 | ₹685 Cr |
How is Total Non-Current Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹1,462 Cr | 17.35 | |
| Mar2023 | ₹1,246 Cr | 8.11 | |
| Mar2022 | ₹1,153 Cr | 68.24 | |
| Mar2021 | ₹685 Cr | - | |
Compare Total Non-Current Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,387.6 Cr | 4.4% | 5.1% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,698.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,866.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,062.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹108,412.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,805.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 4.4% |
5.1% |
-17.8% |
| SENSEX | 0.6% |
0.1% |
9.2% |
You may also like the below Video Courses